SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer.

ABSTRACT:

Importance

Patients with cancer are at increased risk of SARS-CoV-2-associated adverse outcomes.

Objective

To determine the associations of tumor type with SARS-CoV-2 infection, hospitalization, intensive care unit (ICU) admission, and death.

Design, setting, and participants

This retrospective, population-based cohort study included community-dwelling adults aged at least 18 years in Ontario, Canada, ICES-linked provincial health databases from January 1, 2020, to November 30, 2021. Data were analyzed from December 1, 2021, to November 1, 2022.

Exposures

Cancer diagnosis.

Main outcomes and measures

The primary outcome was SARS-CoV-2 infection, and secondary outcomes included all-cause 14-day hospitalization, 21-day ICU admission, and 28-day death follow

SUBMITTER: Hosseini-Moghaddam SM 

PROVIDER: S-EPMC10472189 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature